South San Francisco, CA, United States of America

Eric Sasso

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Eric Sasso

Introduction

Eric Sasso, an accomplished inventor based in South San Francisco, CA, has made significant contributions to the field of medicine with his innovative solutions targeting psoriatic arthritis and axial spondyloarthritis. Holding four patents, Sasso's work reflects a deep commitment to improving patient care through advanced diagnostic methods and predictive modeling.

Latest Patents

Sasso's most recent patents include groundbreaking innovations such as:

1. **Biomarkers and Methods for Assessing Psoriatic Arthritis Disease Activity**: This patent provides biomarkers and methods for generating scores that are critical in assessing disease activity in patients with psoriatic arthritis (PsA). It also includes predictive model methods based on the biomarkers, along with computer systems and software embodiments designed for scoring and classifying samples. Furthermore, the invention recommends optimal therapeutic regimens based on the assessment scores.

2. **Biomarkers and Methods for Measuring and Monitoring Axial Spondyloarthritis Activity**: This innovation introduces biomarkers that are essential for diagnosing and assessing inflammatory disease activity in patients with axial spondyloarthritis (axSpA) and ankylosing spondylitis (AS). The patent provides tools for measuring expression levels of these biomarkers and includes predictive models, computer systems, and software for scoring and classifying samples, thus enhancing monitoring and prognostics for at-risk patients.

Career Highlights

Eric Sasso has had a noteworthy career, bringing his expertise to prestigious organizations in the biotechnology industry. Notably, he has worked with Crescendo Bioscience, a company renowned for its advanced diagnostic solutions in rheumatology. Additionally, he has been associated with Laboratory Corporation of America Holdings (LabCorp), where he contributed to the advancement of clinical laboratory services and diagnostic technologies.

Collaborations

Throughout his professional journey, Sasso has collaborated with talented individuals like Paul Scott Eastman and Scott Eastman. These collaborations have fostered a productive environment for research and development, further enhancing the impact of their collective work on the medical community.

Conclusion

Eric Sasso’s innovative contributions to the field of medicine through his patents highlight his dedication to addressing pressing health issues. His emphasis on biomarkers and predictive models not only serves individuals suffering from psoriatic arthritis and axial spondyloarthritis but also enhances the overall landscape of medical diagnostics. As Sasso continues to drive innovation, his work remains a beacon of hope for improved therapeutic approaches in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…